Objective: Dilation and hypertrophy often occur concurrently in cardiomyopathy, yet the interaction between these two functionally distinct conditions remains unknown. Methods: Combinatorial effects of hypertrophy and dilation were investigated by cross-breeding of two cardiomyopathic transgenic mouse lines which develop either hypertrophy (calcineurin-mediated) or dilation (tropomodulinmediated). Results: Altering the intensity of signals driving hypertrophy and dilation in cross-bred litters resulted in novel disease phenotypes different from either parental line. Augmenting the calcineurin-dependent hypertrophic stimulus in tropomodulin overexpressing transgenics elevated heart:body weight ratios, increased ventricular wall thickness, and significantly accelerated mortality. These effects were evident in calcineurin cross-breeding to tropomodulin backgrounds of transgene homozygosity (severe dilation) or heterozygosity (mild dilation to asymptomatic). Molecular analyses indicated that tropomodulin and calcineurin signaling events in the first week after birth were critical for determination of disease outcome, substantiated by demonstration that temporary neonatal inhibition of tropomodulin expression prevents dilation. Conclusions: This study shows that postnatal timing of altered signaling in cardiomyopathic transgenic mouse models is a pivotal part of determining outcome. In addition, intensifying hypertrophic stimulation exacerbates dilated cardiomyopathy, supporting the concept of shared molecular signaling between hypertrophy and dilation.
defects in cytoskeletal or myofibril organization of the myofibrillogenesis (presumably due to accumulation of cardiomyocyte: deficiency of cytoskeletal-associated musTmod) which can be revealed by calcineurin activation. cle LIM protein [12] or loss of myofibril organization Furthermore, evidence is presented that reaching threshold caused by tropomodulin (Tmod) overexpression [13] .
tropomodulin levels within the first week after birth is Previous work by our group has shown that Tmod overcritical to initiate pathogenesis. Collectively, the results expressing transgenic (TOT) mice develop dilated carshow that superimposing a hypertrophic stimulus to build diomyopathy with a 'failed' hypertrophic response [13] .
myofibrils upon a heart with impaired myofibrillogenesis Dilation in TOT hearts results from calcineurin activation cannot compensate for loss of contractility, but instead which is secondary to the myofibril degeneration caused by exacerbates pathology. Analogous combinatorial condiTmod overexpression [14] . Calcineurin activation, regtions may exist in human cardiomyopathy, in which dilated ulated by increased basal cellular calcium levels, has been cardiomyopathies may benefit from attenuation of signals hypothesized to be a primary pathway for induction of from hypertrophic pathways. hypertrophy [15] . Treatment of TOTs with cyclosporin, a calcineurin inhibitory drug, prevents cardiac dilation without rescuing myofibril organization or affecting mortality [14] . Thus, myofibril degeneration in TOTs was not 2. Methods directly responsible for dilation. Instead, Tmod overexpression is indirectly linked to calcineurin activation, and the 2.1. Creation and breeding of mice failure to hypertrophy stems from impaired myofibrillogenesis in the presence of excessive Tmod protein.
TOTs were created as previously described [13] . TOTs To induce dilated cardiomyopathy in TOTs, Tmod in this study were the offspring of TOT mating pairs. TOT expression levels had to be elevated by breeding to litters in this study were housed together until 3-4 weeks transgene homozygosity [13] . TOTs with heterozygous of age. ATOT mice were created by breeding of homotransgene dosage did not develop any external symptoms zygous TOTs to normal nontransgenic animals. CAL mice of cardiomyopathy which were readily apparent in their were bred to TOT mice to create double heterozygote homozygous siblings. These asymptomatic TOTs (ATOTs) transgenics (CAL-ATOT). CAL-ATOT mice were back presumably lacked threshold levels of Tmod transgene crossed to TOT mice to generate TOT-CAL mice which expression necessary to initiate development of the carwere homozygous for tropomodulin transgene. The indiomyopathic phenotype. In contrast, Tmod accumulation vestigation conforms with the Guide for the Care and Use in TOTs unleashes a cascade of structural and molecular of Laboratory Animals published by the US National effects: after Tmod overexpression causes myofibril disInstitutes of Health (NIH Publication number 85-23, organization, intracellular basal calcium levels rise to revised 1996). increase contractility, followed by activation of calcineurin which drives cardiac dilation [14, 16] . The pathogenesis of TOT dilation depends upon high level Tmod expression to 2.2. Phenotype tracking and database analysis start the chain of molecular events leading to calcineurin activation and eventual dilation. If Tmod protein accumuData gathered on the mouse population was analysed lation is lower in ATOTs and calcineurin is not activated, using PROGENY v2.0 (Genetic Data Systems, Mishawaka, then it is reasonable to predict that dilation would not IN, USA). occur. Despite their seemingly healthy appearance, the possibility remained that ATOTs were compromised by Tmod transgene accumulation, either evidenced as subtle 2.3. Microscopic analyses sarcomeric dysgenesis or a 'silent' defect which could be exacerbated by a complicating stimulus. A secondary 'hit' Gross heart photos were taken using a Nikon microto the ATOT heart in the form of a strong hypertrophic scope. Hematoxylin and eosin stained sections were stimulus could unmask the presence of elevated Tmod scanned using a Nikon LS-3500 slide scanner. Confocal level by inducing rapid myofibril reorganization. Since microscopy and morphometric analyses of heart sections calcineurin activation is the secondary 'hit' which prowere performed as previously described [13] . Sections motes TOT dilation, ATOTs were cross-bred with another were labeled with antibodies to a-actinin to label Z-disks transgenic mouse line which expresses activated calas well as tropomodulin to confirm overexpression of the cineurin in the myocardium. The calcineurin transgenic transgene. Electron microscopy was performed as previ-(CAL) develops marked hypertrophy within 2-3 weeks ously described [17] . All microscopy experiments were after birth [15] . Breeding the ATOT-CAL hybrid combiperformed using three separate individuals analyzed in nation created a novel lethal cardiomyopathic phenotype each group of controls or transgenics at three weeks of age. different from either parental line. Results presented in this Confocal and electron microscopy experiments were perreport indicate that ATOTs indeed carry a 'silent' defect in formed using hearts from different mice.
Gel electrophoresis, immunoblots, and
Tmod time course represents values derived from two immunoprecipitations separate groups of pooled hearts that were tested repeatedly on three separate blot experiments. Minor variation in Equivalent amounts of total protein were separated by sample loading was corrected by standardization to GAP-SDS-PAGE on a 10% gel and transferred to nitrocellulose.
DH signals from the same blot. Tmod expression level was The region corresponding to apparent mobility of Tmod significantly lower in ATOT relative to TOT samples by was excised from the blot and labeled with anti-Tmod comparing the average level from days 1-5 after birth antibody. Bound antibody was detected by labeling with a between the ATOT (average51.5760.57, n542) and TOT Vistra ECF western blot kit (Amersham) as directed by the (average52.0461.0, n555) groups (P50.012). The calmanufacturer. Signal intensity was quantitated using a cineurin time course was repeated on two different groups Storm 860 fluorimager (Molecular Dynamics, Sunnyvale, of pooled heart samples with comparable results in both CA, USA) and calculated as the product of average pixel experiments. intensity in the band multiplied by the area of the band. Immunoprecipitation of calmodulin-calcineurin complexes 2.5. 5-Propyl-2-thiouracil (PTU) treatment of TOT mice was performed as previously described [14] . For analysis of Tmod and calcineurin expression level in ATOT versus PTU treatment was administered by feeding animals a TOT, four hearts were pooled at each time point to diet containing 0.15% PTU (Teklad Premier, Madison, WI, minimize individual variability. Each time point for the USA). TOT mothers were switched to food containing Fig. 1 . ATOT hearts are not functionally or structurally compromised. Working heart analyses (top; control n532 and ATOT n525) or echocardiography (bottom; ATOT n511). (Top) Plots of working heart analyses show measurements of contractility (A) and relaxation (B), respectively assessed by 1 dP/dt and 2 dP/dt, for control nontransgenic (circles) and ATOT hearts as determined using isolated working heart preparations. Hearts from animals ranging in age from ,5 to .50 weeks were tested, yet no significant differences were noted in function between nontransgenic controls and ATOT hearts.
(Bottom) Left ventricular chamber end diastolic dimension for ATOT hearts in multiple animals that were repeatedly examined by echocardiography over a period of several months. Individual animals are represented by different icons (A-K, listed at bottom right side of the plot). No significant changes in the size of the ventricular chamber were noted for any heart throughout the course of the study, demonstrating that ventricular chamber dilation does not occur in ATOTs.
PTU within 1 day of giving birth to the litter. Nursing mothers were maintained on PTU for 1 week and then switched back to normal food. Litters were treated routinely and weaned from the mother at approximately 3 weeks of age. Number of animals for the three time points analyzed in each population were: 21 day untreated (n5 60), treated (n59); 77 day untreated (n516), treated (n5 11); 120 day untreated (n514), treated (n55).
Statistical analysis
Significance values were determined by Student's t-test dent factors and expression level was the dependent factor.
However, a-actinin staining in ATOT sections maintains a regular
An analysis of variance showed that time was not a factor sarcomeric pattern indicative of organized myofibrils.
in determining the significant difference between the groups (data not shown).
Microscopy of ATOT heart sections 3. Results
Confocal microscopy was performed upon sections from 3.1. ATOT heart functional assessments and left ATOT mice to observe myofibril structure (Fig. 2) . ventricular chamber size are normal Nontransgenic control sections showed myofibrillar patters of alternating tropomodulin and a-actinin bands as previ-TOT mice suffer from severe contractility defects and ously described [20] . In comparison, ATOT sections loss of systolic function [13] . To determine if ATOT hearts showed abundant tropomodulin reactivity throughout the suffer any functional impairment, ATOT and nontraninterior of cardiomyocytes ( Fig. 2 ), similar to previous sgenic control hearts were analyzed by isolated working observations with TOT sections [13] . Unlike TOT sections, heart preparation using multiple animals ranging from ,5 a-actinin staining in ATOT sections was well organized to .50 weeks of age ( Fig. 1, top) . Working heart preparacompared to the degeneration evident in TOTs [13] . Ztions were performed as previously described [18] . Condisks of myofibrils viewed by a-actinin staining were tractility and relaxation of ATOT hearts were indistinregularly spaced, aligned, and straight in both control guishable from that of age-matched nontransgenic controls.
nontransgenic and ATOT sections. These results indicate that ATOT hearts are not funcSubtle sarcomeric abnormalities in neonatal TOTs were tionally compromised.
not apparent by confocal microscopy, yet electron microSevere ventricular chamber dilation is a defining characscopy revealed subtle sarcomeric abnormalities [16] . Since teristic of TOT cardiomyopathy [13] . To determine if TOT cardiomyopathy is most severe at 3 weeks after birth ATOT hearts exhibit dilation in vivo, ATOT hearts were [13] , myocardial samples were taken from 3-week-old examined by echocardiography using multiple animals ATOT mice to search for degenerative changes. ATOT which were followed in a longitudinal study over a period samples showed no defects in myofibrils, sarcomeres, of months (Fig. 1, bottom) . Echocardiographic analyses mitochondria, or intercalated discs (Fig. 3) . The arrangewere performed as previously described [19] . Left venment and packing density of myofibrils was normal in tricular end diastolic chamber dimensions did not increase cross-section and sarcomeres showed organized banding. in any of the mice analyzed over the course of the study, Thick and thin filaments were oriented in parallel as in and the average size of the ATOT left ventricular chamber normal controls, unlike samples from TOT mice [13] . (3.960.4) is comparable to previously published values for Well-defined mitochondrial membranes and cristae were age matched nontransgenic control hearts of 3.760. 3 [19] . present, appearing comparable to nontransgenic control This demonstrates that ATOT hearts do not show chamber samples. Normal myofibril and sarcomeric structure obdilation under in vivo working conditions and supports the served by confocal (Fig. 2 ) and electron microscopy (Fig. conclusion that ATOT hearts are not functionally compro-3) supports the idea that myofibril and sarcomeric structure mised.
in ATOT hearts is not significantly affected. 3.3. ATOT mice show elevated tropomodulin levels course investigated, so one representative sample was used. ATOTs ranging in age from young (82 days) to Tmod protein expression level in TOTs was elevated at middle aged (325 days) show marked elevation of Tmod birth and remains chronically high [16] . Lack of pathologilevel relative to the control nontransgenic sample. In cal changes in ATOTs prompted immunoblot analyses to comparison, a typical TOT sample with expression comdetermine if tropomodulin accumulation was decreased parable to previously published levels [13] showed a relative to TOTs. Tmod expression in ATOTs was estihigher Tmod level than any ATOT sample tested. This mated relative to control samples (Fig. 4, nontransgenic survey showed that Tmod is markedly overexpressed in lanes) and quantitative analysis was standardized against older ATOTs, although levels always remain below typical GAP-DH (data not shown). Tmod level in control nontranlevels in TOTs. sgenic animals remained constant throughout the time Abnormally high Tmod levels in neonatal TOTs rise 10 between nontransgenic controls, ATOTs and TOTs (Fig. 6 ). Potential differences due to loading variation were corrected by normalizing to calmodulin levels, and activated calcineurin levels were calculated relative to nontransgenic controls. All three groups showed comparable levels of activated calcineurin at 3 days, although TOTs showed a slight increase above control or ATOTs. At 5 days the TOTs had 2.3-fold more activated calcineurin relative to the control group, whereas ATOTs were slightly elevated at 1.3 fold. At postnatal day 10 the level of activated calcineurin was 1.8-fold higher than controls in both TOT and ATOT samples.
Calcineurin expression exacerbates the pathology of tropomodulin-mediated cardiomyopathy
Cardiomyopathic TOTs described in our previous study were created by selecting for transgene homozygosity [13] . Pathological changes in TOT mice were clearly apparent within two weeks after birth and the majority of TOT early mortality ranges from two to three weeks after birth. In comparison, ATOTs are asymptomatic and show no evidence of cardiomyopathic disease (Figs. 1 and 3) . However, both TOT and ATOT lines exhibit comparable tic 'pumpkin' shape with size and mass comparable in both CAL-TOT and CAL-ATOT crosses (Fig. 7, top row) . rapidly and plateau within one week after birth, initiating a Myocardial pathology continued to worsen in surviving cascade of postnatal molecular signaling which leads to mice as shown for ATOT (Fig. 7 , middle row) and TOT TOT cardiomyopathy [16] . Lowered neonatal Tmod ex- (Fig. 7 , bottom row). pression levels in ATOTs could account for lack of Histologic sections of hearts from parental and hybrid pathological changes compared to TOTs. To test this lines shows overall cardiac enlargement as well as thickenhypothesis, Tmod expression levels within days 1-4 of ing of ventricular walls in CAL-TOT and CAL-ATOT birth were compared between neonatal TOT versus ATOTs crosses (Fig. 8) indicative of hypertrophy. Ventricular wall by quantitative immunoblot analyses. Neonatal ATOTs thickness of 15-day-old nontransgenic controls (n55) was show a trend toward lower tropomodulin expression 0.9360.2 mm for the left and 0.6360.1 mm for the right relative to age-matched TOTs (Fig. 5) . Although expresside. In comparison, ventricular wall thickness of age sion level differences on individual days were not statistimatched CAL-ATOT (n55) was increased 44% for the cally different, the difference in the expression of Tmod in left (1.3460.1 mm) and 41% for the right (0.88560.1 mm) ATOT versus TOT was significant by Student's t-test side. CAL-ATOT ventricular walls were thicker than (P50.012) when overall levels throughout days 1-5 after CAL-TOTs (n52) which increased only 20% for the left birth were compared.
(1.1260.1) and 25% for the right (0.7960.04) sides. The difference in left ventricular wall thickness between CAL-3. 4 
. Calcineurin is activated in ATOT mice
ATOT and CAL-TOT hearts was statistically significant (P50.001), whereas the difference in right ventricular wall Calcineurin activation which occurs in TOT hearts thickness for these two groups approached significance within 5 days of birth [16] has been associated with the (P50.03). Ventricular wall thickness of a typical CAL development of dilation [14] . Levels of calcineurin activaheart ( Fig. 8 ) was 1.53 mm (left) and 0.905 mm (right). tion in the heart were compared at postnatal days 3, 5 and
The unique cardiomyopathy in hybrid lines was distin- guished from either parental strain in morphology, degree enlargement was maintained throughout life, and the of enlargement, and magnitude of ventricular wall hydecrease in ratio with age reflects body weight gain rather pertrophy.
than reduction of cardiac mass. Comparable results were obtained in analysis of CAL-TOT heart:body weight ratios 3.6.
Cross-breeding of CAL to ATOTs or TOTs (data not shown). increases heart:body weight ratios and early mortality
Actuarial data was collected on the population of 49 CAL-ATOT and 12 CAL-TOT mice which died spontaHeart:body weight ratios for CAL-ATOT are elevated neously. Hybrids died as early as 11-12 days after birth, approximately 5-fold above normal nontransgenic values but peak mortality occurred 2-3 weeks after birth (Fig. as early as postnatal day 10, remaining at this level for at 9B). Approximately 70% of CAL-ATOT mice did not least 3-4 weeks after birth (Fig. 9A) . In comparison, survive beyond 3 weeks of age. CAL-TOT mortality heart:body weight ratios for CAL mice between 3-4 weeks peaked in comparable fashion with 75% of the population after birth are increased 3-fold above normal (average dead within 3 weeks of birth (data not shown). Mortality of increase for 10 CAL mice versus 12 age matched nontranthe hybrid lines is markedly higher than parental lines sgenic controls between postnatal days 20-30). Cardiac which showed either no difference from nontransgenic controls (in ATOTs), initial mortality occurring only after 2 months of age (in CAL), or 38% mortality within 3 weeks of birth (in TOTs). Acceleration of mortality in hybrid lines indicated that the cardiomyopathy in crossbred mice was much more severe than the disease in either parental strain. The combinatorial pathologic effect of mixing calcineurin and Tmod transgenes created a novel, more lethal dilated hypertrophic cardiomyopathy. Fig. 7 . Introduction of the CAL into ATOT and TOT causes severe dilated hypertrophic cardiomyopathy. Bisected hearts show the relative degree of cardiomyopathic changes between lines as well as progressive changes over time. All images were processed identically so sizes can be compared between all examples. Postnatal day 16 hearts (top row) from normal nontransgenic and ATOT were comparable in size and shape. In comparison, TOT heart was slightly larger with a dilated ventricular cavity. The hypertrophic CAL heart is larger than normal nontransgenic or TOT hearts. Cross-breeding of either ATOT or TOT to CAL resulted in a novel distorted 'pumpkin' shape. Hypertrophic influence of the CAL transgene is evident by enlargement of CAL-ATOT and CAL-TOT hearts. ATOT and CAL-ATOT hearts from postnatal day 18 (middle row) showed comparable size and shape between normal nontransgenic and ATOT which contrasted sharply with the abnormal dilation of the CAL-ATOT of the same age. Hearts from older CAL-ATOT showed marked chamber dilation with varying degrees of ventricular wall thickening. Note similar size of age-matched CAL-TOT and CAL-ATOT hearts. TOT and CAL-TOT hearts from postnatal days 23 (bottom Fig. 8 . Histologic sections show chamber dilation and ventricular wall row) showed the characteristic dilation of the TOT heart compared to the hypertrophy in CAL-TOT and CAL-ATOT. Comparison of postnatal normal control, whereas the misshapen CAL-TOT heart has marked day 15 hearts prior to development of aberrant shape changes. All images chamber dilation. A 36-day-old CAL-TOT heart showed pathology were processed identically so sizes can be compared between all consistent with progressive dilated and hypertrophic cardiomyopathy.
examples. (Top row) Nontransgenic control heart section was small compared to hypertrophic CAL heart as evidenced by thickened ventricucomparable within 10 days of birth (Figs. 4 and 6 ). lar walls and decreased chamber size. (Middle row) ATOT heart was comparable to nontransgenic control (shown above, see top row), but
Restriction of these transient molecular differences to early CAL-ATOT heart showed combinatorial enlargement and chamber postnatal development suggested the heart was particularly dilation different from either parental line. (Bottom row) TOT heart sensitive to disturbances during this period. To test this showed characteristic dilation compared to control nontransgenic or hypothesis, activation of tropomodulin transgene expres-ATOT although CAL-TOT cross resulted in a dilated and hypertrophic sion in TOTs was delayed by administration of PTU for 1 heart with pathologic changes similar to the CAL-ATOT heart (shown above, see middle row).
week after birth. Following PTU withdrawal, TOTs were reared well beyond the age of 1.5-2 weeks when cardiomyopathic disease normally develops in untreated highly significant decreases in heart:body weight (Fig. 10 ). TOTs [13] . Results of TOT heart:body weight comparisons Differences between PTU-treated and untreated TOT ratios demonstrated a dramatic reduction of heart mass after 1 were all highly significant (P,0.00001). The heart:body week of PTU supplementation. PTU-treated TOTs comweight ratios of the PTU-treated TOTs are comparable to pared to untreated TOTs at three different ages show normal values for control nontransgenic mice [16] . These Fig. 9 . CAL-ATOT heart:body weight ratios and mortality peak within 3 weeks of birth. Heart:body weight ratios (A) and mortality (B) for a CAL-ATOT population of 43 individuals which spontaneously died. (A) The heart:body weight plot shows the average ratio for every two neighboring points on the line. Ratios for animals between 1.5 and 4 weeks of age clustered between a low of 22 to a high of 35. Declining ratios in older mice between 60 and 120 days of age reflect increasing animal body weight without concomitant heart weight gain. The number of mice used to determine the average heart:body weight ratio for every point is represented as bars with a scale on the right hand axis of the plot. (B) Mortality plot shows number of deaths per day versus age in days for CAL-ATOT population. CAL-ATOT mortality peaked between 2-3 weeks after birth, whereas highest TOT mortality splits into two separate peaks occurring at 2 weeks and 3 weeks after birth [16] . Population size of the CAL-ATOT group was 49 individuals.
myofibrillogenesis undergoes a rapid and intense postnatal hypertrophic response (Fig. 11, adapt) . ATOT mice can mount normal postnatal cardiac development but, when challenged with calcineurin activation (CAL-ATOT), cannot adapt to intense hypertrophic signaling and undergo progressive decompensation that leads to accelerated mortality.
The apparent paradox of dilated cardiomyopathy in TOTs versus asymptomatic to mild dilation in ATOTs can be resolved by understanding the importance of early postnatal calcineurin activation in pathogenesis. The cryptic nature of the ATOT phenotype was uncovered by cross-breeding these mice to CAL, which resulted in comparable phenotypes between TOT and ATOT. Since TOT dilation is driven by activated calcineurin, it was reasonable to speculate that levels of calcineurin activation were different in the two lines. Immunoblot analysis confirmed that the time course of calcineurin activation was delayed in ATOT, although by 10 days after birth the levels were comparable between ATOT and TOTs. Similarly, tropomodulin expression in ATOT was lower than in TOT, but only for the first few days after birth. These findings suggest that innocuous ATOT cardiac effects differences in tropomodulin expression and resultant calRatios were calculated at three different time points after birth (21, 77 cineurin activation within the first week after birth. and 120 days), but heart:body weights for the PTU-treated group Neonatal life is a time of rapid cardiac growth and remained constant throughout the course of the study. compensation in response to the workload of systemic circulation [21, 22] . Disruption of neonatal cardiac development leads to cardiomyopathy by altering the molecular results indicate that neonatal expression of Tmod is critical program of growth and hypertrophy. Tropomodulin exfor ensuing development of dilated cardiomyopathy. pression in TOT hearts 'reprograms' cardiac development by calcineurin activation, inducing aberrant hypertrophy during a vulnerable period when structure is susceptible to 4. Discussion the effects of altered signaling. Pathology results from coincidence of critical postnatal cardiac myofibrillogenesis Combinatorial approaches to understand the relative and accumulation of tropomodulin which impairs myofibril roles of dilation and hypertrophy in disease are now assembly. The heart is especially sensitive to disruption of possible using transgenic mice with specific carcontractile function during this developmental time windiomyopathies induced by activation of known signal dow. Compromised heart function during this period transduction pathways. By selective cross-breeding of causes the myocardium to respond with an intense comcardiomyopathic mouse lines, interactions between signal pensatory reaction which sets the stage for carpathways can be assessed for competition, conflict, or diomyopathic disease later in life. If tropomodulin expresmutually exclusive effects. This study used the crosssion levels are attenuated during the first week after birth, breeding approach to examine the relationship between then the phenotype of dilation is averted as shown by Tmod expression and calcineurin activation in the develop-ATOT mice (Fig. 7) and PTU treatment of TOTs (Fig.  ment of cardiomyopathy. Collective results reflecting our 10). Early developmental 'reprogramming' does not occur current understanding of these relationships are summain ATOT because tropomodulin levels are insufficient to rized in Fig. 11 . Although oversimplified, this hypothetical induce calcineurin activation during the vulnerable period. schematic model accounts for the initiation and progresInstead, delayed tropomodulin accumulation in ATOT sion of cardiomyopathic changes described in this study.
hearts renders them 'at risk' for pathological consequences Tmod expression in the TOT line leads to elevation of if challenged during neonatal development. When conintracellular calcium and activation of calcineurin [16] .
fronted with activated calcineurin from the CAL crossHowever, TOT mice are unable to mount a structural breeding, CAL-ATOT hearts manifested cardiomyopathy hypertrophic response and proceed to decompensate (Fig. comparable to CAL-TOT hearts. Thus, ATOT hearts are 11, fail). In contrast, the CAL line capable of normal predisposed to dilated cardiomyopathy which, like TOT disease, is unmasked by early postnatal calcineurin-driven has lost the ability to hypertrophy. Thus, the phenomenon hypertrophy.
of decompensation could be considered dilation in the Although hypertrophy and dilation have distinct funcabsence of concomitant hypertrophy. This is potentially tional consequences, this study suggests that hypertrophy relevant for prophylactic intervention during cardiac hyand dilation are two different endpoints along a shared pertrophy with agents to inhibit chronic stimulation which molecular program of cardiac compensation. Following could eventually result in decompensation. this rationale, if hypertrophy and dilation share a common Cardiomyopathies have been defined in functional terms molecular origin, then downstream events determine the related to systolic or diastolic abnormalities. In addition, relative degree of hypertrophy or dilation. For example, cardiomyopathies are classified by specific structural activation of a normally hypertrophic pathway (calcriteria related to ventricular wall thickness and chamber cineurin) in TOTs leads to dilated cardiomyopathy that is size. Together, functional and structural characteristics the end result of a failed hypertrophic response. TOTs describe progression from diastolic abnormalities (hyperdemonstrate that hypertrophic stimulation superimposed trophy) to systolic insufficiency (dilation) in numerous upon impaired contractility causes dilation, thereby acclinical case reports [23] [24] [25] [26] [27] [28] [29] . The transition to decompencelerating the process of cardiac failure. In this context, sated heart failure involves a marked shift of cardiac end stage dilated heart failure can be thought of as failure function and structure from hypertrophy toward dilated to mount or maintain an appropriate hypertrophic response.
cardiomyopathy. In general, onset of dilation is associated In fact, the transition from hypertrophy to failure shares with poor outcome as systolic function deteriorates [30] , important similarities with overt dilation: increased particularly in infants and children where developmental myofibrillar disarray and loss of contractile function.
processes can exacerbate disease [31, 32] . However, when Decompensated hypertrophic heart failure may be the the transition to heart failure is not abrupt, a mixture of result of ongoing hypertrophic stimulation in a heart which hypertrophic and dilated characteristics evolves in which
